Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo

PubMed

Insights

The c-erbB-2 gene is amplified in some adenocarcinomas, suggesting a role in their development. The epidermal growth factor (EGF) receptor gene (c-erbB-1) is amplified in a small number of squamous-cell carcinomas.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The human genome contains two genes related to the viral erbB gene: c-erbB-1 (epidermal growth factor receptor) and c-erbB-2.
  • c-erbB-2 encodes a receptor-like protein distinct from the EGF receptor.

Purpose of the Study:

  • To investigate the amplification of c-erbB-2 and c-erbB-1/EGF-receptor genes in human malignant tumors.
  • To determine the potential role of these amplified genes in specific cancer types.

Main Methods:

  • DNA hybridization analysis was performed on 101 fresh human malignant tumors.
  • Tumors were analyzed for gene amplification of c-erbB-2 and c-erbB-1/EGF-receptor.

Main Results:

  • The c-erbB-2 gene was amplified in 5 out of 63 adenocarcinomas.
  • No amplification of c-erbB-2 was found in 38 other tumor types.
  • The c-erbB-1/EGF-receptor gene was amplified in 1 out of 8 squamous-cell carcinomas.

Conclusions:

  • Amplification of the c-erbB-2 gene may play a role in the evolution of adenocarcinomas.
  • The EGF receptor gene may be involved in the development of some squamous-cell carcinomas.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...